Cell communication results showed that among all known ligand-receptor pairs, the MDK signal in EGFRvIII mutant GBM was mainly controlled by the ligand MDK and its receptor NCL/PTPRZ1/LRP1 (Fig. S5A–D). The gene discussed is NUCLEOLIN; the disease is glioblastoma.